| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.57 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.06 |